These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 23212752

  • 1. Pre- and postnatal development in the cynomolgus monkey following administration of ABT-874, a human anti-IL-12/23p40 monoclonal antibody.
    Enright BP, Tornesi B, Weinbauer GF, Blaich G.
    Birth Defects Res B Dev Reprod Toxicol; 2012 Dec; 95(6):431-43. PubMed ID: 23212752
    [Abstract] [Full Text] [Related]

  • 2. Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12/23p40 monoclonal antibody, during pregnancy and lactation.
    Martin PL, Sachs C, Imai N, Tsusaki H, Oneda S, Jiao Q, Treacy G.
    Birth Defects Res B Dev Reprod Toxicol; 2010 Oct; 89(5):351-63. PubMed ID: 20540088
    [Abstract] [Full Text] [Related]

  • 3. Developmental immunotoxicology assessment of rituximab in cynomolgus monkeys.
    Vaidyanathan A, McKeever K, Anand B, Eppler S, Weinbauer GF, Beyer JC.
    Toxicol Sci; 2011 Jan; 119(1):116-25. PubMed ID: 20937725
    [Abstract] [Full Text] [Related]

  • 4. Male and female fertility assessment in the cynomolgus monkey following administration of ABT-874, a human Anti-IL-12/23p40 monoclonal antibody.
    Enright BP, Tornesi B, Weinbauer GF, Blaich G.
    Birth Defects Res B Dev Reprod Toxicol; 2012 Dec; 95(6):421-30. PubMed ID: 23213064
    [Abstract] [Full Text] [Related]

  • 5. Effects of SA237, a humanized anti-interleukin-6 receptor monoclonal antibody, on pre- and postnatal development in cynomolgus monkey.
    Katagiri R, Ishihara-Hattori K, Frings W, Amano J, Fuchs A, Chiba S.
    Birth Defects Res; 2017 Jul 03; 109(11):843-856. PubMed ID: 28504465
    [Abstract] [Full Text] [Related]

  • 6. An Enhanced Pre- and Postnatal Development Study in Cynomolgus Monkeys with Tabalumab: A Human IgG4 Monoclonal Antibody.
    Breslin WJ, Hilbish KG, Martin JA, Halstead CA, Newcomb DL, Chellman GJ.
    Birth Defects Res B Dev Reprod Toxicol; 2015 Jun 03; 104(3):100-16. PubMed ID: 26195230
    [Abstract] [Full Text] [Related]

  • 7. Embryo-fetal developmental toxicity of figitumumab, an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in cynomolgus monkeys.
    Bowman CJ, Chmielewski G, Oneda S, Finco D, Boucher MA, Todd M.
    Birth Defects Res B Dev Reprod Toxicol; 2010 Aug 03; 89(4):326-38. PubMed ID: 20540090
    [Abstract] [Full Text] [Related]

  • 8. Postnatal development in cynomolgus monkeys following prenatal exposure to natalizumab, an alpha4 integrin inhibitor.
    Wehner NG, Shopp G, Osterburg I, Fuchs A, Buse E, Clarke J.
    Birth Defects Res B Dev Reprod Toxicol; 2009 Apr 03; 86(2):144-56. PubMed ID: 19283860
    [Abstract] [Full Text] [Related]

  • 9. Developmental toxicity testing of monoclonal antibodies: an enhanced pre- and postnatal study design option.
    Stewart J.
    Reprod Toxicol; 2009 Sep 03; 28(2):220-5. PubMed ID: 19379807
    [Abstract] [Full Text] [Related]

  • 10. Assessment of ixekizumab, an interleukin-17A monoclonal antibody, for potential effects on reproduction and development, including immune system function, in cynomolgus monkeys.
    Clarke DO, Hilbish KG, Waters DG, Newcomb DL, Chellman GJ.
    Reprod Toxicol; 2015 Dec 03; 58():160-73. PubMed ID: 26482726
    [Abstract] [Full Text] [Related]

  • 11. A comparison of effects on reproduction and neonatal development in cynomolgus monkeys given human soluble IL-4R and mice given murine soluble IL-4R.
    Carlock LL, Cowan LA, Oneda S, Hoberman A, Wang DD, Hanna R, Bussiere JL.
    Regul Toxicol Pharmacol; 2009 Apr 03; 53(3):226-34. PubMed ID: 19217923
    [Abstract] [Full Text] [Related]

  • 12. Developmental toxicity assessment of tanezumab, an anti-nerve growth factor monoclonal antibody, in cynomolgus monkeys (Macaca fascicularis).
    Bowman CJ, Evans M, Cummings T, Oneda S, Butt M, Hurst S, Gremminger JL, Shelton D, Kamperschroer C, Zorbas M.
    Reprod Toxicol; 2015 Jun 03; 53():105-18. PubMed ID: 25461901
    [Abstract] [Full Text] [Related]

  • 13. Pre- and postnatal development studies of lasofoxifene, a selective estrogen receptor modulator (SERM), in Sprague-Dawley rats.
    Weisenburger WP, Hagler AR, Tassinari MS.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun 03; 71(3):171-84. PubMed ID: 15282738
    [Abstract] [Full Text] [Related]

  • 14. Placental and Fetal Effects of Onartuzumab, a Met/HGF Signaling Antagonist, When Administered to Pregnant Cynomolgus Monkeys.
    Prell RA, Dybdal N, Arima A, Chihaya Y, Nijem I, Halpern W.
    Toxicol Sci; 2018 Sep 01; 165(1):186-197. PubMed ID: 29893934
    [Abstract] [Full Text] [Related]

  • 15. Embryo/fetal development in cynomolgus monkeys exposed to natalizumab, an alpha4 integrin inhibitor.
    Wehner NG, Shopp G, Oneda S, Clarke J.
    Birth Defects Res B Dev Reprod Toxicol; 2009 Apr 01; 86(2):117-30. PubMed ID: 19278014
    [Abstract] [Full Text] [Related]

  • 16. Reproductive toxicity evaluation of a new camptothecin anticancer agent, CKD-602, in pregnant/lactating female rats and their offspring.
    Chung MK, Kim CY, Kim JC.
    Cancer Chemother Pharmacol; 2007 Feb 01; 59(3):383-95. PubMed ID: 16896929
    [Abstract] [Full Text] [Related]

  • 17. Reproductive safety studies with genistein in rats.
    McClain RM, Wolz E, Davidovich A, Edwards J, Bausch J.
    Food Chem Toxicol; 2007 Aug 01; 45(8):1319-32. PubMed ID: 17433519
    [Abstract] [Full Text] [Related]

  • 18. Effects of maternal exposure to thiamazole on behavioral development in infant cynomolgus monkeys.
    Inoue A, Arima A, Kato H, Yamashita N, Nishida Y, Ooshima Y, Ebihara S.
    Congenit Anom (Kyoto); 2013 Dec 01; 53(4):149-54. PubMed ID: 24712473
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the intramuscular administration of Cervarix™ vaccine on fertility, pre- and post-natal development in rats.
    Segal L, Wilby OK, Willoughby CR, Veenstra S, Deschamps M.
    Reprod Toxicol; 2011 Jan 01; 31(1):111-20. PubMed ID: 20851759
    [Abstract] [Full Text] [Related]

  • 20. Farletuzumab, a monoclonal antibody directed against folate receptor alpha, shows no evidence of teratogenicity in cynomolgus monkeys.
    Moriyama T, Kakiuchi D, Grasso L, Hutto DL, Fernando D, Schweizer C.
    Reprod Toxicol; 2018 Aug 01; 79():89-95. PubMed ID: 29928988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.